Thus, to investigate whether the suppressive effects of AhR and Arnt on CXCL8 and CCL5 were related to ligand-mediated activation, BEAS-2B cells were treated with the AhR antagonist α-naphthoflavone (ANF), prior to PAH exposure. This evidence concerns the gene CCL5 and pulmonary arterial hypertension.